CSBR:NASDAQ
Champions Oncology Inc
USD 4,59
arrow_downward
-1,83%(-0,086) 1D
17 Nov., 14:17:29 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,95 m
Avg. vol.
7,80 k
Volume
4,35 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,95 m
Avg. vol.
7,80 k
Volume
4,35 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
Fox Business
·
20 minute gelede
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
ChartMill
·
1 uur gelede
S&P 500 Most Active Stocks for Nov. 17, 2026
BigGo Finance
·
3 uur gelede
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Traders Union
·
3 uur gelede
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com